NCT06179498 Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
| NCT ID | NCT06179498 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Hepatitis C |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-03-25 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2024-03-25 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).
Eligibility Criteria
Inclusion Criteria: * Self report injecting drugs in the past month * Self report a primary injecting partner (currently inject drugs together) * HCV infection identified at partnering community-based clinical site
Contact & Investigator
Meghan D Morris, MPH, PhD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06179498 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hepatitis C. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06179498 currently recruiting?
Yes, NCT06179498 is actively recruiting participants. Contact the research team at meghan.morris@ucsf.edu for enrollment information.
Where is the NCT06179498 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06179498 clinical trial?
NCT06179498 is sponsored by University of California, San Francisco. The principal investigator is Meghan D Morris, MPH, PhD at University of California, San Francisco. The trial plans to enroll 500 participants.